Fc␥RIIB are low-affinity receptors for IgG that contain an immunoreceptor tyrosine-based inhibition motif (ITIM) and inhibit immunoreceptor tyrosine-based activation motif (ITAM)-dependent cell activation. When coaggregated with ITAM-bearing receptors, Fc␥RIIB become tyrosyl-phosphorylated and recruit the Src homology 2 (SH2) domain-containing inositol 5-phosphatases SHIP1 and SHIP2, which mediate inhibition. The Fc␥RIIB ITIM was proposed to be necessary and sufficient for recruiting SHIP1/2. We show here that a second tyrosine-containing motif in the intracytoplasmic domain of Fc␥RIIB is required for SHIP1/2 to be coprecipitated with the receptor. This motif functions as a docking site for the SH2 domain-containing adapters Grb2 and Grap. These adapters interact via their C-terminal SH3 domain with SHIP1/2 to form a stable receptor-phosphatase-adapter trimolecular complex. Both Grb2 and Grap are required for an optimal coprecipitation of SHIP with Fc␥RIIB, but one adapter is sufficient for the phosphatase to coprecipitate in a detectable manner with the receptors. In addition to facilitating the recruitment of SHIPs, the second tyrosinebased motif may confer upon Fc␥RIIB the properties of scaffold proteins capable of altering the composition and stability of the signaling complexes generated following receptor engagement. (5), i.e. by all receptors containing immunoreceptor tyrosine-based activation motifs. Fc␥RIIB must be coaggregated with activating receptors via IgG immune complexes in order to exert their inhibitory effects (2). The in vivo relevance of the regulatory properties of Fc␥RIIB was ascertained in Fc␥RIIB-deficient mice. Fc␥RIIB Ϫ/Ϫ mice were shown to mount enhanced antibody responses (6), exhibit enhanced IgG-and IgE-induced anaphylactic reactions (7), be hypersensitive to collagen-induced arthritis (8, 9), and develop spontaneous systemic lupus erythematosus in the C57BL/6 background (10). Fc␥RIIB are therefore likely to play major roles in the prevention of autoimmune diseases, allergies, and other inflammatory diseases.The regulatory properties of Fc␥RIIB were shown to depend on the presence of an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its intracytoplasmic domain. This motif was defined as a tyrosine residue that is followed at position Tyr ϩ 3 and preceded at position Tyr Ϫ 2 by hydrophobic amino acids (11). The ITIM tyrosine becomes phosphorylated by a Src family protein tyrosine kinase upon the coaggregation of inhibitory receptors with activating receptors (12), providing a docking site for SH2 domain-containing cytosolic phosphatases (13). Because of the presence of a leucine residue at position Tyr ϩ 2 (14), Fc␥RIIB were shown to recruit selectively the single SH2 domain-containing inositol 5Ј-phosphatases SHIP1 (15, 16) and/or SHIP2 (17). These phosphatases dephosphorylate 5Ј-phosphate groups in 3Ј-phosphorylated inositols and phosphatidylinositides (18, 19) among which phosphatidylinositol 3,4,5-triphosphate (20, 21), generated by phosphatidylinositol 3-kinase duri...